Share This Page

Torah and Dementia

Support & Insight for the Autumn of Life

Drugs

An infusion of antibody therapy for Alzheimer's. (Courtesy of WashU Medicine news release using Getty Images)

Leqembi & Kisunla: Extending Independent Living

February 16, 2025 No Comments

A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.

Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses

February 3, 2025 No Comments

The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.

woman in white shirt holding clear plastic iv bag

What’s Ahead for Alzheimer’s Drugs in 2025

January 12, 2025 No Comments

Learn about 2025’s newly approved or potential Alzheimer’s drugs. These include Leqembi, Kisunla, Remternetug, Semaglutide, Trontinemab and Bepranemab.

Alzheimer's Amyloid Plaques choking neurons

Is Leqembi Shrinking the Alzheimer’s or the Brain?

January 5, 2025 No Comments

Leqembi and Kisunla are the new Alzheimer’s immunotherapies. A loss of brain volume associated with these immunotherapies may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue. A new study sheds light on what’s going on.

Science Director Discussing Lecanemab (Leqembi)

Why Did Europe Finally Choose Lecanemab for Alzheimer’s?

November 28, 2024 No Comments

Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?

Person with dementia and partner on door step

Catching Up to America: Europe Recommends Leqembi® for Alzheimer’s

November 17, 2024 No Comments

The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.

Leqembi Autoinjector to Treat Alzheimer’s in Seconds, Not Hours

November 3, 2024 No Comments

Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.

Lecanemab Beats 3 Competing Antibodies

October 28, 2024 No Comments

Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.

3 Questions on Leqembi & Kisunla, the New Alzheimer’s Drugs

October 21, 2024 1 Comment

The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.

Remternetug May Beat Kisunla for Treating Alzheimer’s

October 8, 2024 No Comments

Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.

Thought of the Week: What We Give

July 17, 2025

We make a living by what we get,But we make a life by what we give. (Winston Churchill)

Avie J. Rainwater, III, Ph.D., ABPP, FAACP

July 17, 2025

Clinical Psychology / Neuropsychology

LIFECARE PSYCHOLOGY GROUP, LLC

MYndspan

July 17, 2025

Empower yourself with a detailed report of your brain’s function, consisting of an assessment of your cognitive function and your brain connectivity with a quick 45-minute on-site appointment.

Most Popular Stories

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?